异基因造血干细胞移植期间血液系统疾病患者的新型冠状病毒2型感染：一例双病例报告
SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.
作者信息
Alexandra Van Uytvanck, Sebastian Wittnebel, Nathalie Meuleman, Angela Loizidou, Jean-Corentin Salengros, Chloé Spilleboudt
机构信息
Institut Jules Bordet Brussels Belgium.
Department of Haematology Institut Jules Bordet Brussels Belgium.
出版信息
Clin Case Rep. 2021 Jul 19;9(7):e04439. doi: 10.1002/ccr3.4439. eCollection 2021 Jul.
Abstract
Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID-19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.
摘要
尽管急性髓系白血病的预处理化疗导致严重免疫抑制，但新型冠状病毒肺炎（COVID-19）并未导致临床病情恶化或死亡，从而引发了免疫抑制治疗对临床病程演变影响的问题。
相似文献
1
SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.异基因造血干细胞移植期间血液系统疾病患者的新型冠状病毒2型感染：一例双病例报告
Clin Case Rep. 2021 Jul 19;9(7):e04439. doi: 10.1002/ccr3.4439. eCollection 2021 Jul.
2
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.新型冠状病毒对造血干细胞移植和嵌合抗原受体 T 细胞治疗受者的影响。
Transplant Cell Ther. 2021 Sep;27(9):796.e1-796.e7. doi: 10.1016/j.jtct.2021.07.005. Epub 2021 Jul 10.
3
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia.病例报告：SARS-CoV-2 阳性受者异基因造血干细胞移植的良好结局，感染与白血病之间的风险效益平衡。
Front Immunol. 2023 May 23;14:1184956. doi: 10.3389/fimmu.2023.1184956. eCollection 2023.
4
Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.接种疫苗的造血干细胞移植受者 COVID-19 结局良好：单中心经验。
Transpl Infect Dis. 2023 Jun;25(3):e14024. doi: 10.1111/tid.14024. Epub 2023 Feb 7.
5
Prolonged SARS-CoV-2 infection during autologous hematopoietic stem cell transplantation from Hodgkin's lymphoma: a case report.自体造血干细胞移植治疗霍奇金淋巴瘤后持续性 SARS-CoV-2 感染：病例报告。
Pan Afr Med J. 2023 Mar 16;44:133. doi: 10.11604/pamj.2023.44.133.36277. eCollection 2023.
6
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.成人急性髓系白血病患者中 SARS-CoV-2 感染的特征、临床结局和危险因素：PETHEMA 组的经验。
Leuk Lymphoma. 2021 Dec;62(12):2928-2938. doi: 10.1080/10428194.2021.1948031. Epub 2021 Jul 22.
7
Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes.奥密克戎相关的 COVID-19 血液病患者防治措施及血液学治疗方案调整策略。
Front Cell Infect Microbiol. 2023 Oct 19;13:1207225. doi: 10.3389/fcimb.2023.1207225. eCollection 2023.
8
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report.异基因造血干细胞移植后骨髓再生不良期间的 SARS-CoV-2 病毒清除：一例报告。
Pediatr Transplant. 2021 Aug;25(5):e13875. doi: 10.1111/petr.13875. Epub 2020 Oct 12.
9
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.异基因造血干细胞移植后早期 COVID-19 的高死亡率：德国合作移植研究组的回顾性多中心分析。
Transplant Cell Ther. 2022 Jun;28(6):337.e1-337.e10. doi: 10.1016/j.jtct.2022.03.010. Epub 2022 Mar 13.
10
[Cytomegaloviral infection in patients with hemoblastoses].[血液病患者的巨细胞病毒感染]
Ter Arkh. 2003;75(7):52-8.
引用本文的文献
1
A COVID-19 Search Engine (CO-SE) with Transformer-based architecture.一种基于Transformer架构的新冠病毒搜索引擎（CO-SE）。
Healthc Anal (N Y). 2022 Nov;2:100068. doi: 10.1016/j.health.2022.100068. Epub 2022 Jun 6.
本文引用的文献
1
COVID-19 in Immunocompromised Hosts: What We Know So Far.免疫功能低下宿主中的 COVID-19：目前我们已知的情况。
Clin Infect Dis. 2021 Jan 27;72(2):340-350. doi: 10.1093/cid/ciaa863.
2
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.成功治疗 SARS-CoV-2 急性呼吸窘迫综合征和新发急性淋巴细胞白血病。
Blood Adv. 2020 Sep 22;4(18):4358-4361. doi: 10.1182/bloodadvances.2020002745.
3
Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge.急性髓系白血病与新型冠状病毒肺炎的并发诊断：一项管理挑战
Cureus. 2020 Aug 9;12(8):e9629. doi: 10.7759/cureus.9629.
4
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.COVID-19 感染血液系统疾病患者的临床特征和死亡风险因素。
Cancer. 2020 Dec 1;126(23):5069-5076. doi: 10.1002/cncr.33160. Epub 2020 Sep 10.
5
Co-diagnoses of acute myeloid leukaemia and COVID-19: presentation and management implications.急性髓系白血病与新型冠状病毒肺炎的合并诊断：临床表现及管理意义
Respirol Case Rep. 2020 Aug 25;8(7):e00650. doi: 10.1002/rcr2.650. eCollection 2020 Oct.
6
COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes.血液系统疾病成年患者的新型冠状病毒肺炎：临床特征与结局分析
Indian J Hematol Blood Transfus. 2021 Jan;37(1):181-185. doi: 10.1007/s12288-020-01318-4. Epub 2020 Jul 7.
7
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.意大利血液系统恶性肿瘤患者中与COVID-19严重程度相关的临床特征和危险因素：一项回顾性、多中心队列研究。
Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
8
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.血液恶性肿瘤住院患者严重急性呼吸综合征冠状病毒 2 感染的区域性结局。
Eur J Haematol. 2020 Oct;105(4):476-483. doi: 10.1111/ejh.13469. Epub 2020 Jul 13.
9
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.COVID-19 与免疫抑制：当前临床经验综述及对接受免疫抑制药物治疗的眼科患者的影响。
Br J Ophthalmol. 2021 Mar;105(3):306-310. doi: 10.1136/bjophthalmol-2020-316586. Epub 2020 Jun 12.
10
Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19.急性白血病患者接受强化化疗并感染新冠病毒后的不良预后。
Bone Marrow Transplant. 2021 Jan;56(1):267-269. doi: 10.1038/s41409-020-0961-y. Epub 2020 Jun 4.
Zotero 插件